FDA inspection
Perrigo New York, Inc.: FDA inspection ending Jul 10, 2003
FDA inspection 278084 · Voluntary Action Indicated (VAI) · Bronx, NY
Key facts
| Inspection ID | 278084 |
|---|---|
| Firm | Perrigo New York, Inc. |
| FEI number | 2450054 |
| Address | 1700 Bathgate Ave |
| City | Bronx |
| State | NY |
| ZIP | 10457-7512 |
| Fiscal year | 2003 |
| Inspection end date | Jul 10, 2003 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Unapproved and Misbranded Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data